Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Guardant Health Inc.

    NASDAQ: GH · Real-Time Price · USD
    51.08
    0.37 (0.73%)
    At close: Jul 02, 2025, 2:46 PM
    0.73%
    Bid 36.78
    Market Cap 6.33B
    Revenue (ttm) 774M
    Net Income (ttm) -416.55M
    EPS (ttm) -3.39
    PE Ratio (ttm) -15.07
    Forward PE -22.35
    Analyst Buy
    Ask 63.74
    Volume 815,980
    Avg. Volume (20D) 2,297,116
    Open 50.75
    Previous Close 50.71
    Day's Range 49.50 - 51.59
    52-Week Range 20.14 - 53.42
    Beta 1.38

    About GH

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol GH
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for GH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    Guardant Health Inc. is scheduled to release its earnings on Aug 6, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    4 weeks ago
    +8.76%
    Guardant Health shares are trading higher after th... Unlock content with Pro Subscription
    2 months ago
    +3.47%
    Guardant Health shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 sales guidance.
    news image

    1 week ago · zacks.com

    TEM vs. GH: Which AI in Precision Oncology Stock Has More Upside Now?

    GH gains ground with stronger guidance, improving margin and Reveal's breakout as TEM scales fast but stays unprofitable.

    news image

    1 week ago · investors.com

    Medical Services Name Flirts With A Buy Point

    This medical services stock is in a cup-with-handle base. The biotech's tests detect cancer through blood tests.

    news image

    3 weeks ago · businesswire.com

    Guardant Health Wins Fast Company's 2025 World Changing Ideas Award for Shield Blood Test for Colorectal Cancer Screening

    PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for colorectal cancer (CRC) screening has been named...

    news image

    3 weeks ago · businesswire.com

    New Study Published in ESMO Open Highlights Guardant Reveal's Performance in Detecting Minimal Residual Disease in Patients with Early-Stage Breast Cancer

    PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced results from the LIBERATE study published in ESMO Open. The results in the...

    news image

    4 weeks ago · fool.com

    Why Guardant Health Stock Surged Nearly 9% Higher Today

    Precision oncology specialist Guardant Health (GH 8.53%) was something of a stock market star on Tuesday. On the back of very positive news in the regulatory sphere, the company's shares jumped almost...

    news image

    4 weeks ago · benzinga.com

    Why Is Cancer Diagnostic Guardant Health Stock Trading Higher On Tuesday?

    Guardant Health, Inc. GH stock is trading higher on Tuesday after the U.S. Food and Drug Administration (FDA) granted Breakthrough Device designation to the company's Shield multi-cancer detection (MC...

    news image

    4 weeks ago · businesswire.com

    FDA Grants Breakthrough Device Designation to Guardant Health's Shield Multi-Cancer Detection (MCD) Test

    PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that its Shield multi-cancer detection (MCD) test has been granted Breakth...

    news image

    1 month ago · businesswire.com

    National Comprehensive Cancer Network (NCCN) Updates Colorectal Cancer Screening Guidelines to Include Shield Blood-Based Screening

    PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the National Comprehensive Cancer Network (NCCN) has included the Shi...

    news image

    1 month ago · businesswire.com

    In Largest Molecular Residual Disease (MRD) Study in Colon Cancer, Guardant Reveal Testing Prior to Chemotherapy Provides Robust Stratification for Risk of Disease Recurrence and Survival to Enable Timely Treatment Decisions

    PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and its research collaborators today presented results of the largest study to date evalua...

    news image

    1 month ago · businesswire.com

    Guardant Health Introduces Nearly a Dozen Groundbreaking Smart Liquid Biopsy Applications for Guardant360 Liquid Test

    PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced major new features for the Guardant 360® Liquid test that greatly expand i...

    Add to Watchlist